Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHG NYSE:FVRR NYSE:MPLN NASDAQ:OABI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHGAkso Health Group$1.63+3.8%$1.75$0.74▼$2.35$866.42M-0.6617,897 shs8,313 shsFVRRFiverr International$23.45-2.4%$23.43$20.83▼$36.11$860.98M1.45851,600 shs454,594 shsMPLNMultiPlan$51.00-0.2%$59.04$4.80▼$29.84$824.72M0.13123,649 shs220,893 shsOABIOmniAb$1.65-1.8%$1.73$1.22▼$4.87$241.85M0.15609,524 shs518,816 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHGAkso Health Group-5.48%-12.04%-9.24%+21.71%+40.18%FVRRFiverr International+2.84%-4.90%+1.41%-13.26%-0.37%MPLNMultiPlan0.00%-0.70%-26.83%+5.71%+467.67%OABIOmniAb+3.07%+4.35%-1.75%-18.84%-57.89%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHGAkso Health Group$1.63+3.8%$1.75$0.74▼$2.35$866.42M-0.6617,897 shs8,313 shsFVRRFiverr International$23.45-2.4%$23.43$20.83▼$36.11$860.98M1.45851,600 shs454,594 shsMPLNMultiPlan$51.00-0.2%$59.04$4.80▼$29.84$824.72M0.13123,649 shs220,893 shsOABIOmniAb$1.65-1.8%$1.73$1.22▼$4.87$241.85M0.15609,524 shs518,816 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHGAkso Health Group-5.48%-12.04%-9.24%+21.71%+40.18%FVRRFiverr International+2.84%-4.90%+1.41%-13.26%-0.37%MPLNMultiPlan0.00%-0.70%-26.83%+5.71%+467.67%OABIOmniAb+3.07%+4.35%-1.75%-18.84%-57.89%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHGAkso Health Group 1.00SellN/AN/AFVRRFiverr International 2.75Moderate Buy$32.6039.02% UpsideMPLNMultiPlan 2.00Hold$12.50-75.49% DownsideOABIOmniAb 2.50Moderate Buy$6.67304.04% UpsideCurrent Analyst Ratings BreakdownLatest OABI, AHG, FVRR, and MPLN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/27/2025AHGAkso Health GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025OABIOmniAbWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/22/2025FVRRFiverr InternationalZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy9/19/2025FVRRFiverr InternationalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$31.009/16/2025FVRRFiverr InternationalOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$35.00 ➝ $30.009/16/2025FVRRFiverr InternationalNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$32.008/7/2025OABIOmniAbRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$4.00 ➝ $3.007/31/2025FVRRFiverr InternationalCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$40.00 ➝ $33.007/31/2025FVRRFiverr InternationalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$35.00 ➝ $28.007/31/2025FVRRFiverr InternationalUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$32.00 ➝ $25.007/31/2025FVRRFiverr InternationalJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Overweight$32.00 ➝ $30.00(Data available from 10/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHGAkso Health Group$14.78M60.86$0.05 per share29.88$0.36 per share4.53FVRRFiverr International$419.13M2.01$1.25 per share18.71$10.12 per share2.32MPLNMultiPlan$930.62M0.89$31.10 per share1.64$105.45 per share0.48OABIOmniAb$26.39M9.00N/AN/A$2.37 per share0.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHGAkso Health Group-$134.98MN/A0.00∞N/AN/AN/AN/AN/AFVRRFiverr International$18.25M$0.4848.8618.76N/A4.34%11.87%4.01%10/29/2025 (Estimated)MPLNMultiPlan-$91.70M-$101.54N/AN/AN/A-163.30%-12.14%-1.84%N/AOABIOmniAb-$62.03M-$0.60N/AN/AN/A-275.83%-22.79%-20.18%11/11/2025 (Estimated)Latest OABI, AHG, FVRR, and MPLN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/29/2025Q3 2025FVRRFiverr International$0.70N/AN/AN/A$107.88 millionN/A8/6/2025Q2 2025OABIOmniAb-$0.14-$0.15-$0.01-$0.15$5.33 million$3.90 million7/30/2025Q2 2025FVRRFiverr International$0.72$0.69-$0.03$0.09$107.75 million$108.65 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAHGAkso Health GroupN/AN/AN/AN/AN/AFVRRFiverr InternationalN/AN/AN/AN/AN/AMPLNMultiPlanN/AN/AN/AN/AN/AOABIOmniAbN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAHGAkso Health GroupN/A14.2014.18FVRRFiverr International0.071.321.32MPLNMultiPlan21.731.051.05OABIOmniAbN/A3.773.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHGAkso Health Group1.21%FVRRFiverr International59.00%MPLNMultiPlan87.15%OABIOmniAb72.08%Insider OwnershipCompanyInsider OwnershipAHGAkso Health GroupN/AFVRRFiverr International15.90%MPLNMultiPlan8.00%OABIOmniAb8.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHGAkso Health Group40551.86 millionN/ANot OptionableFVRRFiverr International79035.84 million30.15 millionOptionableMPLNMultiPlan17016.17 million14.88 millionOptionableOABIOmniAb7143.96 million131.58 millionOptionableOABI, AHG, FVRR, and MPLN HeadlinesRecent News About These CompaniesOmniAb (OABI) Price Target Increased by 10.30% to 8.84October 1, 2025 | msn.comGoldman Sachs Group Inc. Lowers Holdings in OmniAb, Inc. $OABISeptember 26, 2025 | marketbeat.comOmniAb files to sell 21.25M shares of common stock for holdersSeptember 12, 2025 | msn.com227,801 Shares in OmniAb, Inc. $OABI Acquired by Nuveen LLCSeptember 7, 2025 | marketbeat.comOmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 2, 2025 | finance.yahoo.comOmniAb stock falls after announcing $30 million private placementAugust 27, 2025 | za.investing.comOmniAb to raise $30M in private stock placementAugust 25, 2025 | msn.comOmniAb Announces $30 Million Private PlacementAugust 25, 2025 | businesswire.comOmniAb (OABI) Gets a Buy from Craig-HallumAugust 12, 2025 | theglobeandmail.comOmniAb, Inc. (OABI) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comOmniAb Inc (OABI) Q2 2025 Earnings Report Preview: What To ExpectAugust 6, 2025 | finance.yahoo.comOmniAb, Inc. (OABI) Reports Q2 Loss, Lags Revenue EstimatesAugust 6, 2025 | zacks.comOmniAb Reports Second Quarter 2025 Financial Results and Business HighlightsAugust 6, 2025 | businesswire.comOmniAb to Report Second Quarter 2025 Financial Results on August 6July 16, 2025 | businesswire.comPositive week for OmniAb, Inc. (NASDAQ:OABI) institutional investors who lost 47% over the past yearJuly 4, 2025 | finance.yahoo.comChairman of OmniAb Picks Up 3.0% More StockMay 19, 2025 | uk.finance.yahoo.comOmniAb, Inc. (NASDAQ:OABI) Director Steven Love Purchases 25,000 SharesMay 15, 2025 | insidertrades.comInsider Buying: OmniAb, Inc. (NASDAQ:OABI) Director Buys 65,000 Shares of StockMay 14, 2025 | insidertrades.comOmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston SummitMay 13, 2025 | businesswire.comIs OmniAb, Inc. (OABI) the Low Risk High Reward Stock Set to Triple by 2030?May 10, 2025 | insidermonkey.comOmniAb, Inc. (NASDAQ:OABI) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOABI, AHG, FVRR, and MPLN Company DescriptionsAkso Health Group NASDAQ:AHG$1.63 +0.06 (+3.82%) Closing price 03:51 PM EasternExtended Trading$1.59 -0.04 (-2.70%) As of 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.Fiverr International NYSE:FVRR$23.45 -0.57 (-2.37%) Closing price 03:59 PM EasternExtended Trading$23.72 +0.28 (+1.17%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fiverr International Ltd. operates an online marketplace worldwide. Its platform enables sellers to sell their services and buyers to buy them. The company's platform includes various categories in ten verticals, including graphic and design, digital marketing, writing and translation, video and animation, music and audio, programming and tech, business, data, lifestyle, and photography. It also offers value-added products, including subscription-based content marketing, back-office, learning and development offerings, creative talent, and freelancer management platforms. In addition, the company provides a suite of professional solutions that enable businesses to engage with freelancers; Fiverr Pro, a marketplace; Fiverr Certified, a storefront to access certified experts for partner vendors; Fiverr Enterprise, a gateway to source and manage on-demand and long-term freelancers. Further, it offers various value-added products, including Promoted Gigs which allows sellers to advertise their services on the platform; and Seller Plus, a subscription program that equips sellers with advanced tools. The company's buyers include businesses of various sizes, as well as sellers comprise a group of freelancers and agencies. Fiverr International Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.MultiPlan NYSE:MPLN$51.00 -0.09 (-0.18%) As of 10/6/2025MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.OmniAb NASDAQ:OABI$1.65 -0.03 (-1.79%) Closing price 04:00 PM EasternExtended Trading$1.64 0.00 (-0.30%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector 3 Dividend Aristocrats to Buy Before Year’s End The Juice Is Loose: Why Plug Power's Rally Is Just the Beginning Joby's Stock Rallies as Public Flights Validate Global Game Plan SharkNinja Is Flashing a Buy Signal the Market Is Ignoring Why Semtech Stock Is Rallying After Its NVIDIA Setback Marvell Insiders Buy Shares—Should Investors Follow Suit? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
